1. (valid email required)
 

cforms contact form by delicious:days

Segue Manufacturing receives ITAR Registration

December 3, 2008

For Immediate Release

Segue Manufacturing Services announced today that is has acquired ITAR Registration with the US Directorate of Defense Trade Controls (DDTC). ITAR compliance is a key Segue strategic program to support our Military and Homeland security customers to conform to International Traffic in Arms Regulations under 22 CFR 120-130 and the Arms Export Control Act. This program enhances the existing Segue Intellectual Property and Document control policies.

ITAR regulations were designed to control the information and materials of military related technologies. ITAR ensures that military technologies are only shared with US nationals and persons with special exemption from the Department of State. Upon verification of a company’s ITAR compliance, an ITAR Registration Code is assigned and certifies the company’s clearance to work in conjunction with the US military and its counterparts. Additionally, ITAR certification expresses the company’s obligation to handle ITAR protected products while abiding to all ITAR regulations.

Gary Escher (VP of Engineering/Quality) is the Segue Manufacturing ITAR compliance manager in charge the program. He can be reached at 978-970-120 x107 or gescher@segue-mfg.com.. We look forward to discussing our ITAR processes and implementation roadmap with current and prospective customers.

Latest News

Maestro™ for kinetic imaging to be announced at Workshop at WMIC in Kyoto

GlaxoSmithKline, AstraZeneca and other Pharmaceutical Leaders Reduce R&D Time and Costs Using AspenTech’s Software

AspenTech Announces Availability of 7.2 Release of aspenONE V7

CRi Names Darren Lee Vice President of Marketing

Riverside Health System Benefits from New Model of Care Facilitation Powered by Curaspan Health Group

TheBostonChannel.com: “Made in New England”

Aspen Technology Announces Financial Results for the Third Quarter Fiscal Year 2010

Curaspan Health Group President & CEO Thomas R. Ferry Appointed to Epilepsy Therapy Project Board of Directors


Latest Newsletters

July 2010 Newsletter

March 2010 Newsletter

January 2010 Newsletter

October 2009 Newsletter

September 2009 Newsletter

August 2009 Newsletter

July 2009 Newsletter

June 2009 Newsletter


Archives